DKG profile interview with its own Remus Stanescu, Director of Longevity Financial Advisors
Deep Knowledge Group - 12-Jan-2022Highlights some nuances when investing in the longevity industry
Join the club for FREE to access the whole archive and other member benefits.
Venture capital fund that invests in life sciences, cancer research, age-related diseases and regenerative medicine.
Deep Knowledge Group is a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, media, philanthropy and more.
The consortium include Deep Knowledge Ventures, Longevity.Capital, AI-Pharma.Capital, Longevity FinTech Company, Deep Knowledge Analytics, Aging Analytics Agency, NeuroTech Analytics, Biogerontology Research Foundation, Longevity Swiss Foundation, AI-Longevity Consortium at King’s College London, and Longevity International UK - Secretariat for the UK All Party Parliamentary Group for Longevity.
Visit website: https://www.dkv.global
Details last updated 23-Apr-2020
Provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging.
Leading neurotech-focused analytical hub producing advanced analytical reports on the whole scope of neurotech industries.
21-Jun-2022
Club’s launch event featured presentations and panel discussions by a number of Longevity Financial Industry professionals
20-Apr-2022
Event about longevity and healthy life organized by Deep Knowledge Group
Highlights some nuances when investing in the longevity industry
DKG subsidiary to introduce biomarker-driven Longevity risk mitigation and intervention support